FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

18193911000001108: Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Dec 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62434001000001116 Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62434101000001115 Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Is a Pramipexole 1.05mg modified-release tablets true Inferred relationship Existential restriction modifier
Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient Pramipexole true Inferred relationship Existential restriction modifier
Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Pramipexole dihydrochloride monohydrate false Inferred relationship Existential restriction modifier
Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Pramipexole true Inferred relationship Existential restriction modifier
Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Is a Mirapexin true Inferred relationship Existential restriction modifier
Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Pramipexole dihydrochloride monohydrate true Inferred relationship Existential restriction modifier
Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has basis of strength substance Pramipexole true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has AMP True Mirapexin 1.05mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start